Drug & medication recalls Moderate risk

Vancomycin HCI recalled over sterility concerns

Recall date
March 20, 2026
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Fagron Compounding Services recalls Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N…
Recall number
D-0441-2026
FDA classification
Class II
Brand / firm
Fagron Compounding Services
Sold / distributed
Nationwide in the U.S.A.

Why it was recalled

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01

Get recall alerts

Free email alert whenever Fagron Compounding Services has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Fagron Compounding Services